Scott R. Ward
CIK 1174531 · Chairman and CEO · last filed 2026-05-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MDT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
6410 BALLANTINE CT.
INVER GROVE HEIGHTS, MN 55077
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MMSI | Director | 3,457 | $94.20 | $325.6K | $0 | 1 | 2026-05-19 |
| NSPR | Director | 237,096 | $0.45 | $106.7K | $102.6K | 3 | 2026-05-08 |
| Cardiovascular Systems Inc (CSII) Delisted | Chairman and CEO | 232,712 | $20.00 | $4.65M | $159.3K | 34 | 2023-04-27 |
| SURMODICS INC (SRDX) Delisted | Director | 4,207 | $42.98 | $180.8K | $0 | 6 | 2014-12-05 |
| MAP Pharmaceuticals, Inc. (MAPP) Delisted | Director | 0 | $28.11 | $0 | $31.4K | 7 | 2013-03-04 |
| MDT | SVP & Pres CardioVascular | 99,410 | $94.79 | $9.42M | -$2.97M | 31 | 2010-05-04 |
Recent Filings · Page 2 of 9
82 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-02-09 | Cardiovascular Systems Inc (CSII) Delisted | Mixed | +7,977 | $46.3K | EDGAR |
| 2021-08-31 | Cardiovascular Systems Inc (CSII) Delisted | Tax (F) | −4,593 | -$162.5K | EDGAR |
| 2021-08-23 | Cardiovascular Systems Inc (CSII) Delisted | Mixed | −55,479 | -$999.9K | EDGAR |
| 2021-08-17 | Cardiovascular Systems Inc (CSII) Delisted | Tax (F) | −10,570 | -$381.3K | EDGAR |
| 2021-08-11 | Cardiovascular Systems Inc (CSII) Delisted | Grant (A) | +132,563 | $0 | EDGAR |
| 2021-05-11 | Cardiovascular Systems Inc (CSII) Delisted | Buy (P) | +1,000 | $34.4K | EDGAR |
| 2020-09-01 | Cardiovascular Systems Inc (CSII) Delisted | Tax (F) | −4,593 | -$149.8K | EDGAR |
| 2020-08-24 | Cardiovascular Systems Inc (CSII) Delisted | Mixed | −60,558 | -$1.07M | EDGAR |
| 2020-08-17 | Cardiovascular Systems Inc (CSII) Delisted | Buy (P) | +1,000 | $32.2K | EDGAR |
| 2020-08-17 | Cardiovascular Systems Inc (CSII) Delisted | Tax (F) | −9,366 | -$291.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.